Advanced Pharmacology NSG 533
2026 Questions with answers
Course
Advanced Pharmacology NSG 533
1. A patient is prescribed an oral medication that undergoes extensive hepatic metabolism
before reaching systemic circulation. Which pharmacokinetic concept is being described?
A. Protein binding
B. First-pass metabolism
C. Renal clearance
D. Volume of distribution
Answer: B. First-pass metabolism
Rationale: First-pass metabolism occurs when an orally administered drug is absorbed from the
gastrointestinal tract and passes through the liver before reaching systemic circulation. Extensive
first-pass metabolism can substantially reduce bioavailability.
2. Which pharmacokinetic process describes movement of a medication from the
bloodstream into body tissues?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Answer: B. Distribution
Rationale: Distribution is the movement of a drug from systemic circulation into tissues and
body fluids.
3. A medication has a very high volume of distribution. What does this generally suggest?
A. The drug remains primarily within the plasma.
B. A large proportion of the drug distributes into tissues.
C. The drug is eliminated immediately.
D. The drug cannot cross cell membranes.
Answer: B. A large proportion of the drug distributes into tissues.
Rationale: A high volume of distribution generally indicates extensive distribution outside the
plasma compartment.
4. Which organ is the major site of metabolism for many medications?
,A. Liver
B. Heart
C. Spleen
D. Pancreas
Answer: A. Liver
Rationale: Hepatic enzymes, particularly the cytochrome P450 system, metabolize many
medications.
5. A patient with significant hepatic impairment is prescribed a medication extensively
metabolized by the liver. What is the primary concern?
A. Increased drug clearance
B. Potential drug accumulation and toxicity
C. Immediate renal excretion
D. Complete loss of drug activity
Answer: B. Potential drug accumulation and toxicity
Rationale: Reduced hepatic metabolism can decrease drug clearance and increase systemic
exposure, depending on the medication.
6. Which patient factor can significantly affect renal drug clearance?
A. Kidney function
B. Hair color
C. Eye color
D. Height alone
Answer: A. Kidney function
Rationale: Many medications or their metabolites are eliminated through the kidneys. Reduced
renal function can increase exposure to renally cleared drugs.
7. What is the primary purpose of a loading dose?
A. To prevent absorption
B. To rapidly achieve a desired therapeutic concentration
C. To permanently increase drug clearance
D. To eliminate adverse effects
Answer: B. To rapidly achieve a desired therapeutic concentration
Rationale: A loading dose is designed to achieve therapeutic drug concentrations more rapidly
than waiting for repeated maintenance doses alone.
8. Which statement best describes a drug's half-life?
, A. Time required for the drug to begin working
B. Time required for the plasma concentration to decrease by approximately 50%
C. Time required for complete elimination
D. Time required for absorption to begin
Answer: B. Time required for the plasma concentration to decrease by approximately 50%
Rationale: Half-life is the time required for the concentration of a drug in the body or plasma to
decline by approximately one-half.
9. A patient develops a predictable, dose-related adverse effect from a medication. This type
of adverse drug reaction is generally considered:
A. Type A
B. Type B
C. Allergic only
D. Idiosyncratic only
Answer: A. Type A
Rationale: Type A reactions are generally predictable from the drug's known pharmacologic
effects and are often dose related.
10. Which pharmacodynamic concept describes the maximum effect a drug can produce?
A. Potency
B. Efficacy
C. Absorption
D. Clearance
Answer: B. Efficacy
Rationale: Efficacy refers to the maximum effect achievable with a drug. Potency refers to the
amount of drug needed to produce a particular effect.
11. A competitive antagonist is administered with an agonist. What generally occurs?
A. The antagonist permanently destroys the receptor.
B. The agonist's effect can be reduced by competing for the same receptor.
C. The antagonist always produces the same response as the agonist.
D. The agonist becomes more potent automatically.
Answer: B. The agonist's effect can be reduced by competing for the same receptor.
Rationale: Competitive antagonists compete with agonists for receptor binding and can reduce
the agonist's effect.
2026 Questions with answers
Course
Advanced Pharmacology NSG 533
1. A patient is prescribed an oral medication that undergoes extensive hepatic metabolism
before reaching systemic circulation. Which pharmacokinetic concept is being described?
A. Protein binding
B. First-pass metabolism
C. Renal clearance
D. Volume of distribution
Answer: B. First-pass metabolism
Rationale: First-pass metabolism occurs when an orally administered drug is absorbed from the
gastrointestinal tract and passes through the liver before reaching systemic circulation. Extensive
first-pass metabolism can substantially reduce bioavailability.
2. Which pharmacokinetic process describes movement of a medication from the
bloodstream into body tissues?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Answer: B. Distribution
Rationale: Distribution is the movement of a drug from systemic circulation into tissues and
body fluids.
3. A medication has a very high volume of distribution. What does this generally suggest?
A. The drug remains primarily within the plasma.
B. A large proportion of the drug distributes into tissues.
C. The drug is eliminated immediately.
D. The drug cannot cross cell membranes.
Answer: B. A large proportion of the drug distributes into tissues.
Rationale: A high volume of distribution generally indicates extensive distribution outside the
plasma compartment.
4. Which organ is the major site of metabolism for many medications?
,A. Liver
B. Heart
C. Spleen
D. Pancreas
Answer: A. Liver
Rationale: Hepatic enzymes, particularly the cytochrome P450 system, metabolize many
medications.
5. A patient with significant hepatic impairment is prescribed a medication extensively
metabolized by the liver. What is the primary concern?
A. Increased drug clearance
B. Potential drug accumulation and toxicity
C. Immediate renal excretion
D. Complete loss of drug activity
Answer: B. Potential drug accumulation and toxicity
Rationale: Reduced hepatic metabolism can decrease drug clearance and increase systemic
exposure, depending on the medication.
6. Which patient factor can significantly affect renal drug clearance?
A. Kidney function
B. Hair color
C. Eye color
D. Height alone
Answer: A. Kidney function
Rationale: Many medications or their metabolites are eliminated through the kidneys. Reduced
renal function can increase exposure to renally cleared drugs.
7. What is the primary purpose of a loading dose?
A. To prevent absorption
B. To rapidly achieve a desired therapeutic concentration
C. To permanently increase drug clearance
D. To eliminate adverse effects
Answer: B. To rapidly achieve a desired therapeutic concentration
Rationale: A loading dose is designed to achieve therapeutic drug concentrations more rapidly
than waiting for repeated maintenance doses alone.
8. Which statement best describes a drug's half-life?
, A. Time required for the drug to begin working
B. Time required for the plasma concentration to decrease by approximately 50%
C. Time required for complete elimination
D. Time required for absorption to begin
Answer: B. Time required for the plasma concentration to decrease by approximately 50%
Rationale: Half-life is the time required for the concentration of a drug in the body or plasma to
decline by approximately one-half.
9. A patient develops a predictable, dose-related adverse effect from a medication. This type
of adverse drug reaction is generally considered:
A. Type A
B. Type B
C. Allergic only
D. Idiosyncratic only
Answer: A. Type A
Rationale: Type A reactions are generally predictable from the drug's known pharmacologic
effects and are often dose related.
10. Which pharmacodynamic concept describes the maximum effect a drug can produce?
A. Potency
B. Efficacy
C. Absorption
D. Clearance
Answer: B. Efficacy
Rationale: Efficacy refers to the maximum effect achievable with a drug. Potency refers to the
amount of drug needed to produce a particular effect.
11. A competitive antagonist is administered with an agonist. What generally occurs?
A. The antagonist permanently destroys the receptor.
B. The agonist's effect can be reduced by competing for the same receptor.
C. The antagonist always produces the same response as the agonist.
D. The agonist becomes more potent automatically.
Answer: B. The agonist's effect can be reduced by competing for the same receptor.
Rationale: Competitive antagonists compete with agonists for receptor binding and can reduce
the agonist's effect.
